Myconic Capital Announces Closing of Mindscape Ketamine & Infusions Therapy Acquisition

VANCOUVER, British Columbia, April 21, 2021 (GLOBE NEWSWIRE) — Myconic Capital Corp. (formerly, Auralite Investments Inc.) (CSE: MEDI) (FRA: MY0) (the „Company“ or
„Myconic“) is pleased to announce that, further to its press release of March 10, 2021, it has completed the acquisition of all of the issued and outstanding equity of Mindscape
Ketamine & Infusions Therapy, PLLC (“Mindscape”) a